| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.0M | -14.1% |
| Cost of Revenue | $13.6M | -22.0% |
| Gross Profit | $8.4M | +2.6% |
| R&D Expense | $3.2M | -29.8% |
| SG&A Expense | $8.2M | +57.7% |
| Operating Income | -$19.7M | +33.0% |
| Pre-tax Income | -$20.0M | +30.9% |
| Income Tax | -$55K | -227.9% |
| Net Income | -$19.9M | +31.2% |
| EPS (Basic) | -$17.16 | -415.3% |
| EPS (Diluted) | -$17.16 | -415.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | -67.8% |
| Accounts Receivable | $6.1M | +2.2% |
| Inventory | $5.7M | -14.7% |
| Current Assets | $15.8M | -25.8% |
| Total Assets | $22.9M | -24.9% |
| Current Liabilities | $12.0M | +17.7% |
| Total Liabilities | $14.5M | +24.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | +22.5% |
| Capital Expenditures | $16K | — |
| Investing Cash Flow | -$16K | — |
| Financing Cash Flow | $12.2M | — |
| Free Cash Flow | -$16.8M | +22.5% |
| $8.4M |
| -55.4% |